Allergy Therapeutics plc has been mentioned in a Form 8.5 (EPT/RI) disclosure by Panmure Gordon (UK) Limited. The disclosure states that Panmure Gordon (UK) Limited, as an exempt principal trader, has made purchases and sales of Allergy Therapeutics' 0.1p ordinary shares. The purchases involved 395,000 securities at a highest price per unit of 0.014p and a lowest price per unit of 0.014p. The sales involved 200,000 securities at a price per unit of 0.015p. No cash-settled derivative transactions or stock-settled derivative transactions were reported. The disclosure also mentions that there are no indemnity or option arrangements, agreements, or understandings relating to relevant securities. The contact person for the disclosure is Freddie Wooding, with a telephone number of +44 (0)20 7886 2969.